GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Cyclezyme AB (XSAT:CYCLE) » Definitions » Equity-to-Asset

Cyclezyme AB (XSAT:CYCLE) Equity-to-Asset : 0.84 (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Cyclezyme AB Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Cyclezyme AB's Total Stockholders Equity for the quarter that ended in Dec. 2023 was kr6.88 Mil. Cyclezyme AB's Total Assets for the quarter that ended in Dec. 2023 was kr8.15 Mil.

The historical rank and industry rank for Cyclezyme AB's Equity-to-Asset or its related term are showing as below:

XSAT:CYCLE' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.66   Med: 0.77   Max: 0.84
Current: 0.84

During the past 4 years, the highest Equity to Asset Ratio of Cyclezyme AB was 0.84. The lowest was 0.66. And the median was 0.77.

XSAT:CYCLE's Equity-to-Asset is ranked better than
88.01% of 1568 companies
in the Chemicals industry
Industry Median: 0.59 vs XSAT:CYCLE: 0.84

Cyclezyme AB Equity-to-Asset Historical Data

The historical data trend for Cyclezyme AB's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyclezyme AB Equity-to-Asset Chart

Cyclezyme AB Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
0.66 0.73 0.81 0.84

Cyclezyme AB Semi-Annual Data
Dec20 Dec21 Dec22 Dec23
Equity-to-Asset 0.66 0.73 0.81 0.84

Competitive Comparison of Cyclezyme AB's Equity-to-Asset

For the Specialty Chemicals subindustry, Cyclezyme AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cyclezyme AB's Equity-to-Asset Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Cyclezyme AB's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Cyclezyme AB's Equity-to-Asset falls into.



Cyclezyme AB Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Cyclezyme AB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=6.879/8.148
=

Cyclezyme AB's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=6.879/8.148
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cyclezyme AB  (XSAT:CYCLE) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Cyclezyme AB Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Cyclezyme AB's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Cyclezyme AB (XSAT:CYCLE) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Scheelevagen 22, Lund, SWE, 223 63
Cyclezyme AB is a Sweden-based company that has developed an enzymatic platform focused on producing enzymes for green biochemical processes. This platform utilizes biotechnological methods to identify and improve enzymes capable of converting e.g. PET-based plastic materials for new building blocks. The company enables careful experiments and analyses of the behavior of different enzymes in the breakdown of e.g. PET material. The company refines its enzymes and also optimizes the processes for plastic recycling by combining experimental data with data analysis.

Cyclezyme AB (XSAT:CYCLE) Headlines

No Headlines